About Catherine

This author has not yet filled in any details.
So far Catherine has created 4 blog entries.

So what does the “i” in iteams mean?

Running for over a decade, the iteams programme partners multi-disciplinary teams of PhD students and postdocs with inventors from the University of Cambridge.  As we are a recent spin-out from the academic laboratory of our scientific founder Marko Hyvonen, we have had the pleasure of working with an iteam over the last months. The [...]

By | 2018-06-07T07:22:38+00:00 June 6th, 2018|News|Comments Off on So what does the “i” in iteams mean?

Building next generation growth factors for organoid-driven precision medicine: a protein engineering project co-funded by Innovate UK

We were delighted to be awarded Innovate UK funding to address issues of quality and availability of growth factors for use in organoid technologies. The Qkine R&D team are applying a combination of protein expression, refolding optimisation and structure-guided protein engineering to improve the biological properties and quality of proteins such as R-spondins, TGFβ1, members of the BMP and FGF family proteins.

By | 2018-05-08T21:22:59+00:00 May 8th, 2018|News, Organoids, Protein engineering|Comments Off on Building next generation growth factors for organoid-driven precision medicine: a protein engineering project co-funded by Innovate UK

Qkine backed by Cambridge Enterprise and a quintet of angels

University of Cambridge spin-out Qkine has closed its seed investment round supported by Cambridge Enterprise, the commercialisation arm of the University, and a team of five angels led by Jim Warwick. The amount is undisclosed. Qkine is a specialist manufacturer of proteins that are used for control of stem cell growth and differentiation. The backing [...]

By | 2018-04-23T13:13:44+00:00 April 23rd, 2018|News, Press release|Comments Off on Qkine backed by Cambridge Enterprise and a quintet of angels

Cambridge Enterprise and Qkine Ltd sign deal to drive stem cell and regenerative medicine research

Cambridge Enterprise and specialist growth factor manufacturer Qkine Ltd sign key licensing deal for Activin A production technology

By | 2018-04-18T11:46:33+00:00 August 1st, 2017|News|Comments Off on Cambridge Enterprise and Qkine Ltd sign deal to drive stem cell and regenerative medicine research